Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is an oral drug used to relieve pain and inflammation associated with inflammation of the eye. Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is a nonsteroidal anti-inflammatory medicine that contains Diclofenac Sodium as its active ingredient. Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is available in various forms, including ointment, gel, ointment, and spray. Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) works by reducing the pain and inflammation associated with the eye discomfort. Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is used to treat inflammation of the eye and is especially useful for the relief of pain and inflammation associated with eye conditions such as conjunctivitis, corneal ulcers, and blepharoplasty.
Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is used in adults suffering from:
It is also used to relieve inflammation of the eyelid caused by inflammatory diseases of the eyelid (such as blepharitis and corneal ulcers). It may also be used for other conditions, such as:
Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) may be used in different doses. In general, the recommended dose of Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is:
The maximum recommended dose of Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is 200 mg per day, which is higher than the recommended dose of Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) of 1 mg per eye of the same amount.
Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) may cause some patients to feel lightheadedness or fainting when used with alcohol. Therefore, the medication may cause some people to drink large amounts of alcohol before using Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) and for this reason should not drink large amounts of alcohol when using it.
The use of Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) together with some other drugs may increase the risk of side effects.
Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) may also cause some people to be more sensitive to sunlight, particularly when used during the winter months.
It is also sometimes used in children to relieve facial pain and swelling caused by arthritis.
Voltaren Eye Ointment (Diclofenac Sodium Ophthalmic) is a prescription drug.
WIPO Arbitration and Mediation Center
ADMINISTRATIVE PANEL DECISION
F. Hoffmann-La Roche AG v. S.
Case No. D2006-1314
1. The Parties
The Complainant is F. Hoffmann-La Roche AG, Basel, Switzerland, represented by Amneal GmbH, Basel, Switzerland.
The Respondent is S. Teva Pharmaceutical Industries Ltd., S. A., Basel, Switzerland, represented by Teva Pharmaceutical Industries Ltd., S. A.
2. The Domain Name and Registrar
The disputed domain name <voltaren-apodiscounter.com> is registered with.
3. Procedural History
The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on April 28, 2006. On April 29, 2006, the Center transmitted by email to the Registrar a request for registrar verification in connection with the domain name at issue. On May 5, 2006, the Registrar transmitted by email to the Center its verification response confirming that the Respondent is listed as the registrant and providing the contact details for the administrative, billing, and technical contact. The Center verified that the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2(a) and 4(a), the Center formally notified the Respondent of the Complaint, and the proceedings commenced on June 2, 2006. In accordance with the Rules, paragraph 5(a), the due date for Response was July 5, 2006. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on July 14, 2006.
The Center appointed Martin J. Cappas as the sole panelist in this matter on July 30, 2006. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.
The Panel has determined that it is properly constituted.
4. Factual Background
The Complainant is a pharmaceutical company which develops, manufactures and distributes prescription pharmaceutical products in the world. The Complainant is an authorized supplier of the trademark Voltaren® (diclofenac sodium acetate; USP) and the trademark Voltaren® (diclofenac sodium acetate; USP) in the United States. The Complainant owns a trademark Voltaren® (diclofenac sodium sodium acetate; USP), which is used in the USP trademark. Voltaren® is a generic version of the trademark Diclofenac Sodium, which is used in the USP trademark. The Complainant has marketed the Diclofenac Sodium product in the USP trademark and has launched a pharmaceutical product for the relief of pain and/or fever. The Diclofenac Sodium product has been licensed for use by the Complainant in the USP trademark. The Complainant is a supplier of the Diclofenac Sodium product in the USP trademark. The Complainant has a manufacturing facility in the United States.
The Complainant is engaged in manufacturing, selling, supplying and distributing the Diclofenac Sodium product for the relief of pain and/or fever. The Complainant has an international licensing arrangement with the United States Food and Drug Administration (“FDA”) in December 2006. The Complainant is licensed to manufacture and market the Diclofenac Sodium product in the USP trademark.
The Complainant has a trademark Voltaren® (diclofenac sodium sodium acetate; USP), which is used in the USP trademark. The Complainant has a manufacturing facility in the USP trademark.
Don’t let strong pain keep you from doing what matters most to you. Change the game and get back to your best with Voltaren Emulgel™. Voltaren Emulgel™ penetrates deep into your skin and replaces the guesswork work carried out by painkillers only.
The active ingredient in Voltaren Emulgel™ is diclofenac which belongs to a class of medications called non-steroidal anti-inflammatory drugs (NSAIDs). Diclofenac works to stop the growth of certain types of arthritis, fibromyalgia (gastritis), menstrual cramps, and minor injuries that may contribute to pain and inflammation.
Ingredients
Each film-coated, Emulgel™ tablet contains diclofenac d 0.1%.
The active ingredient in Voltaren Emulgel™ is diclofenac d 20. This ingredient is very similar to the ingredient in Voltaren® gel™.
Warnings
DO NOT USE VILAREEmulgel™ IF YOU VEGuate under the age of 18 or if you are pregnant or breastfeeding.
Do not use on children under 12 years of age.
Diclofenac Diethylammonium 23.6 mg
Active Ingredients: Diclofenac diethylamine 23.6 mgDo not use Voltaren Emulgel if you are allergic to diclofenac, other anti-inflammatory medicines (including aspirin and ibuprofen), aspirin or ibuprofen, or any of the other ingredients of this leaflet.
Talk to your doctor before using this product if you are pregnant, planning to become pregnant, or breastfeeding.
Directions
Adults 18 years of age and over: Apply the product as directed by your doctor 5 times a day. Do not use for more than 7 days or give up if symptoms do not get better. Keep using for at least 14 days. If your symptoms do not subside after using the product, talk to your doctor.
Diclofenac Diethylamine 23.6 mg/g
Active ingredient: Diclofenac diethylamine 23.6 mg
Other ingredients: (in each film-coated gel tablet) Lactose.
Do not use Voltaren Emulgel if you are pregnant or trying to become pregnant or breastfeeding.
Do not use Voltaren Emulgel if you are in the last 3 months of your pregnancy or if you are breast-feeding for at least 6 months after your delivery.
Talk to your doctor before using this product if you are in the first 6 months of a new pregnancy or if you are expecting.
Diclofenac Diethylamine 20 mg
Active ingredient: Diclofenac diethylamine 20 mgVoltaren Emulgel is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve muscle pain, arthritis, and backache pain. It relieves mild to moderate pain caused by a variety of conditions, including rheumatism, acute inflammation, and strains and bones. Voltaren Emulgel is available as a gel, a cream, or a capsule.
Voltaren Emulgel contains the anti-inflammatory ingredient diclofenac diethylamine, which works by blocking the effects of an enzyme called cyclooxygenase (COX), which helps reduce the synthesis of pro-inflammatory chemicals in the body. This enzyme plays a role in the synthesis of chemicals in the body that cause inflammation and swelling. In Voltaren Emulgel, the use of diclofenac diethylamine increases the levels of diclofenac in the body and enhances the effects of the enzyme. This helps to reduce symptoms of muscle and joint pain and accelerates the recovery time.
Voltaren Emulgel is a topical anti-inflammatory medication that is used to relieve pain and inflammation in conditions such as backache, muscle strains, sprains, and strains and sports injuries. It works by reducing the production of prostaglandins, chemicals that cause pain and inflammation, and this is particularly useful for muscle and back pain. Voltaren Emulgel can be used to relieve sprains, strains, and strains in both adults and children. Voltaren Emulgel is not intended for use by children.
Voltaren Emulgel is available in three different forms, each each needs to be applied twice daily:
It is important to inform your healthcare provider about any of the following conditions before using Voltaren Emulgel. These conditions include:
Do not use Voltaren Emulgel if you are allergic to diclofenac, aspirin, or any of its ingredients. Do not use Voltaren Emulgel if you have had an allergic reaction to diclofenac, aspirin, or any of its ingredients. Before using Voltaren Emulgel, inform your doctor if you have or have had any liver, kidney, or heart disease, any heart problems, or if you have any problems with your heart. Do not use Voltaren Emulgel if you are pregnant or breastfeeding. For Voltaren Emulgel, consult the leaflet included with your medication.
Strain (headache, backache, muscle aches, sore muscles, fever, sore throat, soreness in your legs)The most common side effects of Voltaren Emulgel include skin redness, itching, swelling, and a slight metallic taste in the mouth. The side effects may be mild or severe and do not last long. Contact your healthcare professional if the symptoms persist or worsen. They may adjust your dosage or recommend a different medication. You should contact your healthcare professional immediately if you experience any stomach pain, constipation, gas, or diarrhea. Other less common side effects include blurred vision, sensitivity to light, and difficulty distinguishing between blue and green colors. Rarely, Voltaren Emulgel may cause a skin rash, which may be more likely to be a result of a fungal infection. If you experience any of these and have already had them, let your healthcare professional know. You may report side effects to FDA at 1-800-FDA-1088.
StoreKeep Voltaren Emulgel out of reach of children. Store the gel at room temperature, away from heat and moisture. Do not store the topical product in the bathroom. Keep Voltaren Emulgel out of the reach of children.
Voltaren is a nonsteroidal anti-inflammatory drug (NSAID) widely used to treat pain, inflammation, and tissue thinning in the body. It belongs to the fentanyl family of drugs and is a selective cyclooxygenase-2 (COX-2) enzyme. v is involved in the production of prostaglandins and lipids involved in various physiological processes, including inflammation, pain, and fever.
The global market for Voltaren has been steadily growing over the years. In the year ended 31 of 2012, the market was valued at approximately $45.8B.
The Voltaren market is segmented by cause; safety ($8.3B); and clinical effectiveness ($10.2B). The safety by cause$8.3B is driven by the selective selectivity of fentanyl, the selective action of anti-inflammatory drugs, and the selective action of cyclooxygenase-2 (COX-2) inhibitors.
Stade de France Pharmacy